We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
1226
DELISTED
2seventy bio
TSVT
| $2.57M | ﹤0.01% |
667,023
+223,408
| +50% | +$1.01M |
|
1227
Remitly
RELY
$4.91B
| $2.56M | ﹤0.01% |
+211,262
| New | +$3.28M |
|
1228
iShares Russell 1000 ETF
IWB
$47.6B
| $2.56M | ﹤0.01% |
+8,592
| New | +$2.47M |
|
1229
O-I Glass
OI
$1.15B
| $2.55M | ﹤0.01% |
+229,236
| New | +$3.1M |
|
1230
Smith & Nephew
SNN
$13.7B
| $2.55M | ﹤0.01% |
102,722
+73,960
| +257% | +$1.85M |
|
1231
Gladstone Investment Corp
GAIN
$650M
| $2.54M | ﹤0.01% |
181,454
-58,847
| -24% | -$827K |
|
1232
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $2.54M | ﹤0.01% |
27,800
+20,400
| +276% | +$1.81M |
|
1233
Matrix Service
MTRX
$316M
| $2.54M | ﹤0.01% |
255,297
-9,449
| -4% | -$108K |
|
1234
GeoPark
GPRK
$605M
| $2.53M | ﹤0.01% |
231,220
-156,223
| -40% | -$1.56M |
|
|
VBTX
1235
DELISTED
Veritex Holdings
VBTX
| $2.53M | ﹤0.01% |
+120,031
| New | +$2.43M |
|
1236
Helios Technologies
HLIO
$2.51B
| $2.53M | ﹤0.01% |
52,999
+14,908
| +39% | +$714K |
|
1237
Phillips Edison & Co
PECO
$5.51B
| $2.53M | ﹤0.01% |
+77,241
| New | +$2.52M |
|
1238
Theravance Biopharma
TBPH
$875M
| $2.52M | ﹤0.01% |
297,499
+135,426
| +84% | +$1.22M |
|
|
PLGO
1239
Pelagos Insurance Capital
PLGO
$2.17B
| $2.52M | ﹤0.01% |
154,663
+138,144
| +836% | +$2.45M |
|
|
NAPA
1240
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $2.52M | ﹤0.01% |
+354,815
| New | +$2.86M |
|
1241
Celcuity
CELC
$4.01B
| $2.49M | ﹤0.01% |
152,291
+43,476
| +40% | +$727K |
|
1242
iShares Biotechnology ETF
IBB
$9.49B
| $2.48M | ﹤0.01% |
+18,089
| New | +$2.41M |
|
1243
Cabaletta Bio
CABA
$432M
| $2.47M | ﹤0.01% |
330,187
+159,000
| +93% | +$1.95M |
|
|
JNPR
1244
DELISTED
Juniper Networks
JNPR
| $2.46M | ﹤0.01% |
+67,600
| New | +$2.4M |
|
|
IOBT
1245
DELISTED
IO Biotech
IOBT
| $2.46M | ﹤0.01% |
2,105,262
| – | – |
|
1246
Grupo Aeroportuario del Pacifico
PAC
$13B
| $2.46M | ﹤0.01% |
15,787
+1,391
| +10% | +$241K |
|
1247
Newmont
NEM
$95.7B
| $2.44M | ﹤0.01% |
58,287
-370,909
| -86% | -$15.2M |
|
1248
Black Hills Corp
BKH
$5.6B
| $2.44M | ﹤0.01% |
44,870
-68,110
| -60% | -$3.71M |
|
|
OLPX
1249
DELISTED
Olaplex Holdings
OLPX
| $2.43M | ﹤0.01% |
1,575,802
-1,315,267
| -45% | -$2.1M |
|
1250
International Seaways
INSW
$4.69B
| $2.42M | ﹤0.01% |
40,961
+17,259
| +73% | +$1.01M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.